Deadly drug-resistant fungal infections rising in the U.S.

A potentially deadly type of fungus that is almost untreatable continues to pose severe threats to healthcare facilities across the U.S., a new government study found.Limited time: Save 25% on NBC News subscriptionGet exclusive reporting, live Q&As and ad-free reading.Candida auris, or C.

auris, is a yeast that can cause serious illness in people with weakened immune systems.Since the fungus was first identified in the U.S.

in 2016, more than half of states have reported cases.From 2022 to 2024, 13,507 C.

auris cases were reported to the Centers for Disease Control and Prevention, with steady and significant increases each year.Most of the cases were in men over 45, in hospitals and in healthcare facilities, according to the report released Tuesday.

The CDC collected the data, which state and jurisdictional health departments submitted voluntarily.The CDC didn’t include deaths from C.

auris.An earlier study found that about 30% of people infected with the fungus die.

C.auris can accumulate on the skin, which scientists call “colonization.” Getting rid of it isn’t easy.“Sometimes the fungi sits on our skin and becomes a part of our ecosystem,” said Dr.

Waleed Javaid, chief quality officer of West Virginia University Hospitals and professor of medicine in the infectious diseases division.Healthy people typically are asymptomatic, but those with compromised immune systems or coping with other illnesses are at high risk of infection.

The fungus can cause minor skin irritations or dangerous bloodstream infections.It can live for a long time on the skin and spreads easily to surfaces or to people who have open wounds, Javaid said.It “might sit on a wound and cause infection, and that is the problem we want to resolve,” he said.Once it is detected in a facility, rooms need to be sterilized with hospital-grade disinfectants, Javaid said.

Symptoms of a C.auris infection include fever and chills, similar to bacterial infections.In the new report...